Our Blog

AVITA Medical (ASX:AVH) files RECELL application with FDA

02 Jun 2020 – AVITA Medical (ASX:AVH) has submitted an Investigational Device Exemption (IDE) supplement with the US Food and Drug Administration (FDA) for a clinical trial to investigate the RECELL® System for the treatment of vitiligo.


Source: Finance News Network

Share this post